Data Discovery Award supports dementia researchers with early access to UKB-PRISM neuroproteomics data to understand disease mechanisms, improve risk prediction and support therapeutic development.
Funder: Alzheimer's Research UK
Due Dates: January 6, 2027, 12 noon (Application) | March 2027 (Funding outcome)
Funding Amounts: Up to £100,000 for a maximum of 12 months
Summary: Supports data-driven dementia research through funded exclusive early access to the UKB-PRISM neuroproteomics dataset.
Key Information: Lead and joint lead applicants must be based at a UK university, hospital, or research institution.
Alzheimer’s Research UK’s Data Discovery Award supports ambitious research using the UK Biobank Proteomics for Risk Identification and Signatures of brain health in Midlife (UKB-PRISM) dataset before its public release through UK Biobank. The resource links blood-based neuroproteomic measurements from 80,000 samples with genetic, imaging, clinical and longitudinal health data. Successful applicants receive funded exclusive early access through phased data releases during the award.
The programme welcomes biological, clinical, epidemiological, computational, statistical, translational and methodological research. Priorities include understanding disease mechanisms, improving risk prediction and patient stratification, supporting therapeutic development, developing analytical approaches, and creating tools or community resources. Proposals should explain why UKB-PRISM is uniquely suited to their objectives, particularly its population-scale, longitudinal and multimodal strengths, and generate meaningful outputs for the wider dementia research community.